Cell Signaling Technology

PathScan® Phospho-FGFR2 (panTyr) Sandwich ELISA Kit

#7954 · $661

100
Citing papers
7k
Combined citations
Supplier page Find this product

Research areas

Wnt/β-catenin signaling in development and cancer11Cancer, Hypoxia, and Metabolism10TGF-β signaling in diseases9Cancer-related gene regulation7Cancer Cells and Metastasis7Inflammasome and immune disorders6Per- and polyfluoroalkyl substances research5Developmental Biology and Gene Regulation5

Papers citing this product

1
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Nature Communications·2012·824 cit.·DOI
2
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Nature Communications·2017·440 cit.·DOI
3
SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells<b><i>In vitro</i></b>and<b><i>In vivo</i></b>
Cancer Research·2004·411 cit.·DOI
4
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
Biochemical Journal·2005·396 cit.·DOI
5
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Nature Communications·2017·342 cit.·DOI
6
Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome
Nature Communications·2021·231 cit.·DOI
7
Apc-mutant cells act as supercompetitors in intestinal tumour initiation
Nature·2021·207 cit.·DOI
8
Notch1 is an effector of Akt and hypoxia in melanoma development
Journal of Clinical Investigation·2008·207 cit.·DOI
9
Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase Inhibitor
Cancer Research·2006·186 cit.·DOI
10
Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS
Blood·2008·178 cit.·DOI
PathScan® Phospho-FGFR2 (panTyr) Sandwich ELISA Kit — Evidence — PubIndex